The pharmaceutical company Eczacibasi Group plans to invest over EUR 250m in its operations, create more than 1,500 new jobs, and reach an annual turnover of over EUR 150m in 2022 when it celebrates its 80th anniversary, according to Atalay Gumrah, CEO of Eczacibasi. “We’ll primarily develop our R&D activities in nuclear medicine and invest...
Latest News:
Macroprudential measures can’t replace monetary policy: TUSIAD
Digital transformation of Chinese commercial banks: OPINION
The sustainable advantages of purchasing second-hand products
It’ll be enough to manage until the election!
What matters on Wednesday, January 25
Startups receive USD 1.6bn funding in 2022
Domestic tourism expenditures skyrocket
Consumer confidence hits 16-month high
What matters on Monday, January 23
Izmir to hold an economy congress for the second century of the republic
Central Bank keeps interest rate steady at 9%
What matters on Wednesday, January 18
What matters on Tuesday, January 17
Budget deficit hits TRY 139.1bn in 2022
‘The climate crisis is on top of our agenda’
What matters on Friday, January 6
Economy to retract in 1H, recover in 2H
What matters on Thursday, January 5
Has anyone seen a decrease in prices?
Home
Atalay Gumrah